These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 9859763)
1. Detection of breast cancer cells using the magnetic cell separation (MACS) system: implications for stem cell purging. Garau D; Regazzi E; Savoldo B; Sammarelli G; Rizzoli V; Carlo-Stella C Eur J Histochem; 1997; 41 Suppl 2():17-8. PubMed ID: 9859763 [No Abstract] [Full Text] [Related]
2. Removal of breast cancer cells by soybean agglutinin in an experimental model for purging human marrow. Morecki S; Margel S; Slavin S Cancer Res; 1988 Aug; 48(16):4573-7. PubMed ID: 3396008 [TBL] [Abstract][Full Text] [Related]
3. Purging of contaminating breast cancer cells from hematopoietic stem cell grafts by adenoviral GAL-TEK gene therapy and magnetic antibody cell separation. Marini FC; Snell V; Yu Q; Zhang X; Singletary SE; Champlin R; Andreeff M Clin Cancer Res; 1999 Jun; 5(6):1557-68. PubMed ID: 10389945 [TBL] [Abstract][Full Text] [Related]
4. Purging breast cancer cells in preparation for autologous bone marrow transplantation. Morecki S; Pavlotzky F; Margel S; Slavin S Bone Marrow Transplant; 1987 Apr; 1(4):357-63. PubMed ID: 3332143 [TBL] [Abstract][Full Text] [Related]
5. Purging of human breast cancer cells from stem cell products with an adenovirus containing p53. Hirai M; Kelsey LS; Vaillancourt M; Maneval DC; Watanabe T; Talmadge JE Cancer Gene Ther; 2000 Feb; 7(2):197-206. PubMed ID: 10770627 [TBL] [Abstract][Full Text] [Related]
6. [Immature dendritic cells directional differentiated from murine hemopoietic stem cells and morphous and function of them by MACS]. Jiang YZ; Tian PX; Ding XM; Xue WJ; Ding CG Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Oct; 23(10):917-20. PubMed ID: 17908498 [TBL] [Abstract][Full Text] [Related]
7. Biological purging of breast cancer cell lines using a replication-competent oncolytic virus in human stem cell autografts. Thirukkumaran CM; Luider JM; Stewart DA; Alain T; Russell JA; Auer IA; Forsyth P; Morris DG Bone Marrow Transplant; 2005 Jun; 35(11):1055-64. PubMed ID: 15821774 [TBL] [Abstract][Full Text] [Related]
8. Characterization of antibody binding to three cancer-related antigens using flow cytometry and cell tracking velocimetry. Chosy EJ; Nakamura M; Melnik K; Comella K; Lasky LC; Zborowski M; Chalmers JJ Biotechnol Bioeng; 2003 May; 82(3):340-51. PubMed ID: 12599261 [TBL] [Abstract][Full Text] [Related]
9. [Effect of immunomagnetic selection in purging autologous peripheral blood progenitor cell of breast cancer patients]. Han X; Shi Y; Zhang W Zhonghua Yi Xue Za Zhi; 2002 Feb; 82(3):203-6. PubMed ID: 11953162 [TBL] [Abstract][Full Text] [Related]
10. Detection of disseminated epithelial cancer cells by liquid culture--factors interfering with the standardization of assays. Krüger WH; Lange A; Badbaran A; Gutensohn K; Kröger N; Zander AR Cytotherapy; 2003; 5(3):252-8. PubMed ID: 12850794 [TBL] [Abstract][Full Text] [Related]
11. Genetically engineered fluorescent cell marker for labeling CD34+ hematopoietic stem cells. Ye K; Jin S; Schultz JS Biotechnol Prog; 2004; 20(2):561-5. PubMed ID: 15059003 [TBL] [Abstract][Full Text] [Related]
12. Mouse A6-positive hepatic oval cells also express several hematopoietic stem cell markers. Petersen BE; Grossbard B; Hatch H; Pi L; Deng J; Scott EW Hepatology; 2003 Mar; 37(3):632-40. PubMed ID: 12601361 [TBL] [Abstract][Full Text] [Related]
13. Ex-vivo purging of hematopoietic progenitor cells. de Lima M; Shpall EJ Curr Hematol Rep; 2004 Jul; 3(4):257-64. PubMed ID: 15217555 [TBL] [Abstract][Full Text] [Related]
14. Similarity and differences between the haemopoietic and brain stem cell system. Uchida N Symp Soc Exp Biol; 2001; (53):21-8. PubMed ID: 12063845 [No Abstract] [Full Text] [Related]
15. Detection of circulating tumour cells in patients with breast or ovarian cancer by molecular cytogenetics. Engel H; Kleespies C; Friedrich J; Breidenbach M; Kallenborn A; Schöndorf T; Kolhagen H; Mallmann P Br J Cancer; 1999 Dec; 81(7):1165-73. PubMed ID: 10584878 [TBL] [Abstract][Full Text] [Related]
16. Pulsed electric fields for selection of hematopoietic cells and depletion of tumor cell contaminants. Eppich HM; Foxall R; Gaynor K; Dombkowski D; Miura N; Cheng T; Silva-Arrieta S; Evans RH; Mangano JA; Preffer FI; Scadden DT Nat Biotechnol; 2000 Aug; 18(8):882-7. PubMed ID: 10932160 [TBL] [Abstract][Full Text] [Related]
17. Tumor cell purging by ex vivo expansion of hemopoietic stem cells from breast cancer patients combined with targeting ErbB receptors. Leone F; Cavalloni G; Gunetti M; Pignochino Y; Piacibello W; Aglietta M Biol Blood Marrow Transplant; 2006 Jan; 12(1):68-74. PubMed ID: 16399570 [TBL] [Abstract][Full Text] [Related]
18. The efficiency of magnetic-activated cell sorting and fluorescence-activated cell sorting in the decontamination of testicular cell suspensions in cancer patients. Geens M; Van de Velde H; De Block G; Goossens E; Van Steirteghem A; Tournaye H Hum Reprod; 2007 Mar; 22(3):733-42. PubMed ID: 17082221 [TBL] [Abstract][Full Text] [Related]
19. Factors limiting the efficiency of immunomagnetic cell separation. Mansour V; Weiler M; Gee A Prog Clin Biol Res; 1992; 377():169-79. PubMed ID: 1438413 [No Abstract] [Full Text] [Related]
20. Re: Selection of stem cells by using antibodies that target different CD34 epitopes yields different patterns of T-cell differentiation. Sutherland DR; Keeney M Stem Cells; 2007 Sep; 25(9):2385-6. PubMed ID: 17569789 [No Abstract] [Full Text] [Related] [Next] [New Search]